X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67) 67
index medicus (66) 66
adult (50) 50
male (49) 49
female (47) 47
infectious diseases (47) 47
middle aged (44) 44
hiv infections - drug therapy (39) 39
immunology (31) 31
virology (24) 24
hiv (22) 22
aged (21) 21
cd4 lymphocyte count (21) 21
hiv infections - virology (21) 21
aids (20) 20
aids/hiv (20) 20
human immunodeficiency virus--hiv (20) 20
viral load (20) 20
microbiology (19) 19
antiretroviral therapy (18) 18
hiv infections - immunology (17) 17
antiretroviral drugs (16) 16
drug therapy (16) 16
anti-hiv agents - therapeutic use (15) 15
pharmacology & pharmacy (15) 15
young adult (15) 15
hiv-1 - drug effects (14) 14
treatment outcome (14) 14
anti-hiv agents - administration & dosage (13) 13
cohort studies (13) 13
hiv-1 (12) 12
adolescent (11) 11
double-blind method (11) 11
individuals (11) 11
article (10) 10
prospective studies (10) 10
efficacy (9) 9
epidemiology (9) 9
health aspects (9) 9
human-immunodeficiency-virus (9) 9
infection (9) 9
pharmacokinetics (9) 9
rna, viral - blood (9) 9
acquired immune deficiency syndrome--aids (8) 8
analysis (8) 8
clinical trials (8) 8
drug therapy, combination (8) 8
hiv infection (8) 8
ritonavir (8) 8
active antiretroviral therapy (7) 7
antiretroviral therapy, highly active (7) 7
ccr5 receptor antagonists (7) 7
disease progression (7) 7
germany (7) 7
hiv infections - blood (7) 7
hiv-1-infected patients (7) 7
infections (7) 7
reverse transcriptase inhibitors - therapeutic use (7) 7
risk factors (7) 7
safety (7) 7
aged, 80 and over (6) 6
animals (6) 6
anti-hiv agents - adverse effects (6) 6
antiviral agents (6) 6
drug resistance, viral (6) 6
expression (6) 6
genotype (6) 6
germany - epidemiology (6) 6
hematology (6) 6
immune activation (6) 6
immunodeficiency-virus type-1 (6) 6
mortality (6) 6
pharmacology (6) 6
protease inhibitors (6) 6
research (6) 6
time factors (6) 6
610 medicine & health (5) 5
adults (5) 5
anti-hiv agents - pharmacokinetics (5) 5
care and treatment (5) 5
drug administration schedule (5) 5
drug resistance (5) 5
drugs (5) 5
efavirenz (5) 5
europe (5) 5
hiv infections - epidemiology (5) 5
hiv-1 - genetics (5) 5
hiv-1 - isolation & purification (5) 5
human immunodeficiency virus (5) 5
maraviroc (5) 5
medicine (5) 5
nosocomial infections (5) 5
prevalence (5) 5
prognosis (5) 5
ribonucleic acid--rna (5) 5
ritonavir - therapeutic use (5) 5
rna (5) 5
therapy (5) 5
triazoles - therapeutic use (5) 5
viruses (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS ONE, ISSN 1932-6203, 09/2011, Volume 6, Issue 9, pp. e23946 - e23946
Background/Aim of the Study: The study aimed to determine the cost impacts of antiretroviral drugs by analysing a long-term follow-up of direct costs for... 
INDIVIDUALS | THERAPY | PRICE | DRUGS | EMTRICITABINE | BIOLOGY | INFECTION | STRATEGIES | REDUCE | LIFE | Anti-HIV Agents - pharmacology | Anti-HIV Agents - economics | Follow-Up Studies | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Drugs, Generic - economics | Reverse Transcriptase Inhibitors - pharmacology | Male | Drugs, Generic - therapeutic use | Protease Inhibitors - pharmacology | Drug Prescriptions - economics | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Protease Inhibitors - therapeutic use | Drugs, Generic - pharmacology | Reverse Transcriptase Inhibitors - economics | Protease Inhibitors - economics | Drug Therapy, Combination - economics | Drug Prescriptions - statistics & numerical data | HIV Infections - drug therapy | Cost Savings - statistics & numerical data | Germany | Cohort Studies | Highly active antiretroviral therapy | Medical research | Generic drugs | Protease inhibitors | Proteases | Analysis | Economic aspects | Medicine, Experimental | HIV (Viruses) | Health care | Drugs | Antiretroviral drugs | Therapy | Costs | Ritonavir | Medical treatment | Resource allocation | Medical services | Cost reduction | Data processing | Disease control | Antiretroviral therapy | Prescription drugs | Inhibitors | Taxes | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Taxation | Cost analysis | Cost engineering | Pharmaceuticals | Index Medicus | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2008, Volume 198, Issue 8, pp. 1113 - 1122
Background. Vicriviroc (VCV) is a CCR5 antagonist with nanomolar activity against human immunodeficiency virus (HIV) replication in vitro and in vivo. We... 
HIV/AIDS | Tropisms | RNA | HIV | Placebos | Viruses | AIDS | Infections | Dosage | HIV 1 | Virology | INFECTIOUS DISEASES | MYOCARDIAL-INFARCTION | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | PROGNOSTIC VALUE | CCR5 ANTAGONIST | INDIVIDUALS | ANTIRETROVIRAL-DRUG-RESISTANCE | SYNCYTIUM-INDUCING PHENOTYPE | EPIDEMIOLOGY | DISEASE PROGRESSION | Piperazines - administration & dosage | Lamivudine - administration & dosage | Humans | Male | RNA, Viral - blood | Reverse Transcriptase Inhibitors - administration & dosage | Viral Load | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | HIV-1 - physiology | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | CCR5 Receptor Antagonists | Benzoxazines - administration & dosage | Double-Blind Method | Zidovudine - adverse effects | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | HIV Infections - virology | Benzoxazines - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Piperazines - therapeutic use | Piperazines - adverse effects | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | HIV Infections - drug therapy | Zidovudine - therapeutic use | Lamivudine | Dosage and administration | HIV (Viruses) | Drug therapy | Zidovudine | Index Medicus | Abridged Index Medicus
Journal Article
Nature Structural and Molecular Biology, ISSN 1545-9993, 10/2016, Volume 23, Issue 10, pp. 906 - 915
Journal Article
Virology, ISSN 0042-6822, 2010, Volume 406, Issue 1, pp. 12 - 20
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2017, Volume 23, Issue 2, pp. 185 - 191
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9712, pp. 396 - 407
Journal Article
by Mocroft, Amanda and Lundgren, Jens D and Sabin, Miriam Lewis and Monforte, Antonella d'Arminio and Brockmeyer, Norbert and Casabona, Jordi and Castagna, Antonella and Costagliola, Dominique and Dabis, Francois and de Wit, Stéphane and Fätkenheuer, Gerd and Furrer, Hansjakob and Johnson, Anne M and Lazanas, Marios K and Leport, Catherine and Moreno, Santiago and Obel, Niels and Post, Frank A and Reekie, Joanne and Reiss, Peter and Sabin, Caroline and Skaletz-Rorowski, Aiane and Suarez-Lozano, Ignacio and Torti, Carlo and Warszawski, Josiane and Zangerle, Robert and Fabre-Colin, Céline and Kjaer, Jesper and Chene, Genevieve and Grarup, Jesper and Kirk, Ole and Lundgren, Jens and Sabin, Miriam and Johnson, Anne and Lazanas, Mario and Post, Frank and Suarez-Loano, Ignacio and Johnson, Hansjakob Furrer Anne and Touloumi, Giota and Meyer, Laurence and Dabis, François and Krause, Murielle Mary and Ghosn, Jade and de Wolf, Frank and Prins, Maria and Bucher, Heiner and Gibb, Diana and Hamouda, Osamah and Bartmeyer, Barbara and del Amo, Julia and Thorne, Claire and Stephan, Christoph and Pérez-Hoyos, Santiago and Noguera-Julian, Antoni and Antinori, Anea and Monforte, Antonella d' Arminio and Ramos, José and Battegay, Manuel and Rauch, Ani and Mussini, Cristina and Tookey, Pat and Miro, Jose M and de Wit, Stephane and Goetghebuer, Tessa and Teira, Ramon and Garrido, Myriam and Judd, Ali and Haerry, David and Weller, Ian and Schwimmer, Christine and Termote, Monique and Touzeau, Guillaume and Campbell, Maria and Friis-Møller, Nina and Bohlius, Julia and Bouteloup, Vincent and Cozzi-Lepri, Alessano and Dorrucci, Maria and Egger, Matthias and Engsig, Frederik and Lambotte, Olivier and Lewden, Charlotte and Lodwick, Rebecca and Matheron, Sophie and Miro, Jose and Paredes, Roger and Phillips, Anew and Puoti, Massimo and Scherrer, Alexana and Smit, Colette and Sterne, Jonathan and Thiebaut, Rodolphe and von Wyl, Viktor and Wittkop, Linda and Late Presenters Working Grp and Collaboration Observational HIV Ep and Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
PLoS medicine, ISSN 1549-1277, 2013, Volume 10, Issue 9, pp. e1001510 - e1001510
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 6/2009, Volume 199, Issue 11, pp. 1638 - 1647
Background. Maraviroc, a CCR5 antagonist, is active against R5 but not X4 or dual- or mixed-tropic strains of human immunodeficiency virus type 1 (HIV-1). A... 
HIV/AIDS | Tropisms | Medical treatment failures | RNA | Antivirals